AstraZeneca taps Chinese biotech in $5.2bn chronic disease research deal

admin_news

Jun 13, 2025 - 22:00

0 0

AstraZeneca taps Chinese biotech in $5.2bn chronic disease research deal

What's Your Reaction?

Like 0

Dislike 0

Love 0

Funny 0

Angry 0

Sad 0

Wow 0

Related Posts

BlackRock to reassess Australian exposure amid stretche...

admin_news Feb 27, 2025 0 0

Stock market today: Dow, S&P 500, Nasdaq futures climb ...

admin_news Feb 27, 2025 0 0

On The Hunt For Magnificent Earnings Growth? Check Thes...

admin_news Feb 27, 2025 0 0

Stock Futures Rebounding Ahead of Key Nvidia Earnings

admin_news Feb 27, 2025 0 0

Super Micro Jumps After Filing Delayed Financial Reports

admin_news Feb 27, 2025 0 0

China to Inject at Least $55 Billion of Fresh Capital I...

admin_news Feb 27, 2025 0 0

Comments

google.com, pub-7219625775647229, DIRECT, f08c47fec0942fa0